Medicinal application of long synthetic peptide technology.


Autoria(s): Corradin G.; Spertini F.; Verdini A.
Data(s)

2004

Resumo

This review covers the latest developments of long synthetic peptide technology for the rapid identification and development of malaria vaccine candidates and immunological modulators. A brief description of the two most common solid-phase synthetic procedures, together with the latest advances in optimisation of peptide chain assembly and analytical instrumentation, is given, with special attention to non-specialists. Several examples of vaccine candidates developed in the authors' or their collaborators' laboratories are also provided.

Identificador

http://serval.unil.ch/?id=serval:BIB_D8A7EF59A754

isbn:1744-7682[electronic]

pmid:15461574

doi:10.1517/14712598.4.10.1629

isiid:000224515300008

Idioma(s)

en

Fonte

Expert opinion on biological therapy, vol. 4, no. 10, pp. 1629-39

Palavras-Chave #Animals; Antigens, Protozoan; B-Lymphocytes; Bee Venoms; Chemistry, Organic; Clinical Trials as Topic; Epitopes; Humans; Hypersensitivity, Immediate; Malaria Vaccines; Mice; Mice, Inbred BALB C; Peptides; Phospholipases A; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; T-Lymphocyte Subsets; Vaccines, Subunit; Vaccines, Synthetic
Tipo

info:eu-repo/semantics/review

article